Biological Collection in Nephrology for the Study of the Links Between Kidney Disease, Immunity System and Cardiovascular Complications (NéphroMIC²)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03305211|
Recruitment Status : Not yet recruiting
First Posted : October 9, 2017
Last Update Posted : October 9, 2017
The NephoMIC project is a biological collection in patients of Nephrology, allowing the study of the links between kidney diseases, Immunity system and Cardiovascular complications.
Its aim is to allow the development of a translational research on the theme of "Systemic Nephrology", which concerns both renal complications of autoimmune and inflammatory diseases, and systemic complications of patients with kidney disease, linked to both a state of immunosuppression and an increased risk of cardiovascular complications.
It is based on the proximity between the Clinical investigation Center (CIC) of the hospital, where the samples are received, techniqued and preserved, and the Center of Nephrology and Renal Transplantation of the hospital.
The collection includes blood samples (whole blood, serum, plasma, total blood RNA, PBMC cells), and urine samples (fresh urine).
Participation in the collection is particularly recommended for patients who require a medical renal biopsy in the Nephrology Department. Other well-phenotyped patients (well-defined renal disease diagnosis) may also participate in NephroMIC.
|Condition or disease||Intervention/treatment||Phase|
|Kidney Disease||Other: sample||Not Applicable|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||600 participants|
|Intervention Model:||Single Group Assignment|
|Intervention Model Description:||patients requiring renal biopsy for medical reasons|
|Masking:||None (Open Label)|
|Official Title:||Biological Collection in Nephrology for the Study of the Links Between Kidney Disease, Immunity System and Cardiovascular Complications|
|Estimated Study Start Date :||December 15, 2017|
|Estimated Primary Completion Date :||December 15, 2022|
|Estimated Study Completion Date :||April 20, 2023|
biological sampling will be performed on patients requiring renal biopsy and well-phenotyped patients (diagnosis of renal disease)
Participation in NephroMIC involves additional blood samples of 5 tubes (35 mL) and an additional sample of fresh urine.
- Blood and urinary biomarkers in renal disease [ Time Frame: one day ]biological assay
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03305211
|Contact: Noémie JOURDE-CHICHE||04 91 38 30 firstname.lastname@example.org|
|Assistance Publique des Hôpitaux de Marseille Hôpital de la Conception||Not yet recruiting|
|Marseille, France, 13354|
|Contact: Noémie JOURDE-CHICHE 04 91 38 30 42 email@example.com|
|Study Director:||Urielle DESALBRES||Assistance Publique Hôpitaux de Marseille|